High Drug Costs: Industry Perspective

By Jennifer Ludden

Published October 17, 2004 at 12:00 AM EDT

NPR's Jennifer Ludden talks with Dr. Paul Antony, chief medical officer for the Pharmaceutical Research and Manufacturers of America. He offers the drug industry's perspective on the rising costs of prescription drugs, and responds to charges made Saturday by Dr. Marcia Angell, who accuses pharmaceutical companies of spending too much on advertising and making undue profits.

NPR Health

Jennifer Ludden

Jennifer Ludden helps edit energy and environment stories for NPR's National Desk, working with NPR staffers and a team of public radio reporters across the country. They track the shift to clean energy, state and federal policy moves, and how people and communities are coping with the mounting impacts of climate change.

See stories by Jennifer Ludden

High Drug Costs: Industry Perspective

Email address